Log In
Print
BCIQ
Print
Print this Print this
 

Carbavance

  Manage Alerts
Collapse Summary General Information
Company The Medicines Co.
DescriptionCombination of RPX7009, a boron-containing beta lactamase (LACTB) inhibitor, and meropenem, a carbapenem antibiotic
Molecular Target Beta lactamase (LACTB)
Mechanism of ActionBeta lactamase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today